Injective, Litecoin price forecast as KangaMoon grows

Injectable ( INJ ) prices have dropped below $40 and may struggle despite recent network developments. Litecoin (LTC) could break above $100 and see more upside amid ETF speculation. Elsewhere in the market, investors are buying Kang Moon (KANG) heavily.

Litecoin (LTC) is seeing some action on news coverage as Inject (INJ) price sits at a critical support level. The two cryptocurrencies are among investors who are watching the sentiment surrounding Bitcoin give way to the bigger picture for top altcoins.

Here's a Litecoin price forecast and Injector to see why new crypto project KangaMoon (KANG) is gaining interest.

Table of Contents

Toggle

Litecoin price prediction among LTC news

Litecoin sat among the top altcoins for a while before falling off the radar amid negative price action during the last bear market.

Now, while Bitcoin is hoarding all the headlines at a rapid pace to a new all-time high, Litecoin's price is slowly falling back into the shadows. A new bully may be in the limelight.

Last week, Coinbase Derivatives triggered an interest injection for LTC with plans to list Litecoin futures. The derivative product will go live on April 1. On Tuesday, the CFTC named LTC and ETH as commodities in its lawsuit against crypto exchange KuCoin.

There is speculation that institutions may be looking at LTC spot exchange-traded funds (ETFs). The coin's similarity to Bitcoin suggests that the SEC may be more open to it than Ethereum.

While the ETF rumor may be long-winded, if bulls strengthen above $100, the bullish outlook for Litecoin's value will come into play.

LTC jumped more than 10% to a high of $98.90 late Tuesday. If the price breaks the immediate resistance line, it could retest the area around $130. New tailwinds at these levels could push LTC/USD above $200 for several years.

Injective (INJ) has been in the dark since falling from an all-time high of $52.60 on March 14. INJ is currently trading at $38.35, down more than 5% in the last 24 hours.

The price of INJ is therefore hovering near a key support line that has presented an opportunity for buyers to load for several periods on a year-to-date basis.

Injective's latest weakness comes as investors weigh the lawsuit against KuCoin and the impact its two founders could have on the market.

The US Department of Justice indicted the two Kucoin executives for criminal trespass and KCS's price plummeted due to the influx of funds.

However, Injective has shown significant network growth. Its Ionic update could be a big step as the network becomes more interoperability with Ethereum, Soland and other chains. A bullish reversal could help the bulls recover above $50 and reach new all-time highs.

If the bulls fail to regain their dominance, a retreat to range trading is possible from the 40-$35 key boundaries. The upper range may be $45, while bears may look for the $30 support level.

KangaMoon (KANG) is a new crypto token in presale. Although it has yet to enter the commercial market, it is attracting a lot of attention for its innovative project and native token KANG.

Driving Kangamun is Tokinomics' own creation, which sees participants start earning KANG through various challenges and competitions before the sale. There may be a unique approach because this is a meme coin project that combines SocialFi and play-to-income.

There is a chance that Kanga Moon will grow into a top project in the P2E space, especially with rare NFTs and game fighting platform fun.

To date, the project has raised more than $2.8 million from early investors. The current level 4 is almost 40% off, with the price at a relative bargain point of $0.014. KANG price increased from $0.005 in level 1.

Kanga Moon is likely to be one of the projects that explodes when tokens are launched on exchanges after the pre-sale.

In particular, those who join the pre-sale now can get a 10% bonus on all purchases. Buying options include USDC, USDT, SOL, BNB, ETH and BTC.

See the Kanga Moon website for more details.